Analyst Ratings for Pacira Pharmaceuticals (PCRX) [Buys]
PCRX Rating Summary
PCRX Price Target Summary
- Highest: $24.00 (Jefferies)
- Lowest: $15.00 (Piper Jaffray)
- Average: $19.00
Overall Rating:
BUY
Rating Trend:
=
Avg. $ Target:
$19.00 (-35.2%)
| Date | Firm | Type | Rating (Past) |
PT (Past) |
Start $ | End $ | % Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 1/27/2012 | Jefferies » Updated 1/18/2013 |
New Coverage | Buy (N/A) |
24.00 (22.00) |
9.10 | 29.30 | 221.98% | Details |
| 12/9/2011 | Barclays » Updated 8/14/2012 |
New Coverage | Overweight (N/A) |
19.00 (12.00) |
8.15 | 29.30 | 259.51% | Details |
| 3/17/2011 | Brean Capital | New Coverage | Buy (N/A) |
N/A (N/A) |
6.85 | 29.30 | 327.74% | Details |
| 3/16/2011 | Wedbush » Updated 8/9/2012 |
New Coverage | Outperform (N/A) |
18.00 (N/A) |
6.84 | 29.30 | 328.36% | Details |
| 3/15/2011 | Piper Jaffray » Updated 3/28/2012 |
New Coverage | Overweight (N/A) |
15.00 (N/A) |
6.87 | 29.30 | 326.49% | Details |
